Merck’s Keytruda Gains Medicare Negotiation Reprieve With Expanded Orphan Exemption

 
• By Cathy Kelly
  
The delay for Keytruda could mean billions in lost savings for Medicare. (Shutterstock)

More from Medicare

More from United States